The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 5, 2006, Pages 1389-1394

  Barbera, Lisa ^a,b,c   Paszat, Lawrence ^a,b,c   Thomas, Gillian ^a,b   Covens, Al ^a,b   Fyles, Anthony ^b,d   Elit, Laurie ^e,f   Qiu, Feng ^c  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Institute for Clinical and Evaluative Services   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e JURAVINSKI CANCER CENTRE   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Cervix cancer; Chemotherapy; Patterns of Care; Practice guidelines guideline adherence; Radiotherapy; Treatment

Indexed keywords

PATIENT MONITORING; RADIOTHERAPY; TUMORS;

CERVIX CANCER; PATTERNS OF CARE; PRACTICE GUIDELINES/GUIDELINE ADHERENCE; TREATMENT;

CHEMOTHERAPY;

ANTINEOPLASTIC AGENT;

ARTICLE; BRACHYTHERAPY; CHEMOTHERAPY; COMORBIDITY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DRUG THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ONTARIO; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 33645337378     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.09.046     Document Type: Article

References (32)

1. W.C. Smith, A.J. Lee, I.K. Crombie Control of blood pressure in Scotland The rule of halves BMJ 300 1990 981 983
2. W.J. Rogers, L.J. Bowlby, N.C. Chandra Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction Circulation 90 1994 2103 2114
3. M.D. Laverick, S.A. Croal, R.A. Mollan Orthopaedic surgeons and thromboprophylaxis BMJ 303 1991 549 550
4. R. Grol, J. Grimshaw From best evidence to best practice Effective implementation of change in patients' care Lancet 362 2003 1225 1230
5. G.P. Browman Improving clinical practice guidelines for the 21st century. Attitudinal barriers and not technology are the main challenges Int J Technol Assess Health Care 16 2000 959 968
6. H.M. Keys, B.N. Bundy, F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma New Engl J Med 340 1999 1154 1161
7. P.G. Rose, B.N. Bundy, E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer New Engl J Med 340 1999 1144 1153
8. M. Morris, P.J. Eifel, J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer New Engl J Med 340 1999 1137 1143
9. W.A. Peters III, P.Y. Liu, R.J. Barrett Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
10. C.W. Whitney, W. Sause, B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes A Gynecology and Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
11. National Cancer Institute NCI clinical announcement 1999 United States Department of Health and Human Services, Public Health Service, National Institutes of Health Bethesda, MD
12. E.A. Clarke, L.D. Marrett, N. Kreiger Cancer registration in Ontario A computer approach O.M. Jenson D.M. Parkin R. MacLennan Cancer registration principles and methods 1991 IARC Publications Lyon, France 246 257
13. S.C. Robles, L.D. Marrett, E.A. Clarke An application of capture-recapture methods to the estimation of completeness of cancer registration J Clin Epidemiol 41 1988 495 501
14. R. Wilkins PCCF + version 3G users guide Automated geographic coding based on the Statistics Canada postal code conversions files 2001 Statistics Canada Ottawa
15. R.A. Deyo, D.C. Cherkin, M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
16. P.J. Eifel, J. Moughan, B. Erickson Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix A patterns of care study Int J Radiat Oncol Biol Phys 60 2004 1144 1153
17. E.L. Trimble, L.C. Harlan, L.X. Clegg Untreated cervical cancer in the United States Gynecol Oncol 96 2005 271 277
18. H. Lukka, H. Hirte, A. Fyles Primary treatment for locally advanced cervical cancer: Concurrent platinum-based chemotherapy and radiation. Program in evidence based care: A Cancer Care Ontario Program. Toronto 2002
19. E.M. Antman, J. Lau, B. Kupelnick A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction JAMA 268 1992 240 248
20. M.D. Cabana, C.S. Rand, N.R. Powe Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
21. M. Saunders, S. Dische, A. Barrett CHART Steering Committee Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial Lancet 350 1997 161 165
22. M. Saunders, S. Dische, A. Barrett CHART Steering committee Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer Mature data from the randomised multicentre trial Radiother Oncol 52 1999 137 148
23. F. Macbeth An uncharted country Clin Oncol (R Coll Radiol) 11 1999 71 72
24. D.S. Alberts, P.Y. Liu, E.V. Hannigan Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 1996 1950 1955
25. M. Markman, B.N. Bundy, D.S. Alberts Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma An intergroup study of the Gynecology Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 2001 1001 1007
26. D.K. Armstrong, B.N. Bundy, R. Baergen Randomized phase III study of intravenous (IV) paclitaxel and cisplatin versus IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC) A Gynecology Oncology Group Trial (GOG 172) [Abstract] Proc Am Soc Clin Oncol 2002 803
27. K. Fujiwara, M. Markman, M. Morgan Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer Gynecol Oncol 97 2005 10 15
28. R. Pearcey, M. Brundage, P. Drouin Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966 972
29. D.A. Grimes Technology follies. The uncritical acceptance of medical innovation JAMA 269 1993 3030 3033
30. L.K. Mell, J.C. Roeske, A.J. Mundt A survey of intensity-modulated radiation therapy use in the United States Cancer 98 2003 204 211
31. A. Pollack, G.K. Zagars, L.G. Smith Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer J Clin Oncol 18 2000 3904 3911
32. M.J. Zelefsky, Z. Fuks, M. Hunt High-dose intensity modulated radiation therapy for prostate cancer Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116